Healthcare utilization and indirect cost of treatment associated with severe allergic asthma in a real-world setting

Documenti analoghi

• Healthcare Resource Utilization in Patients Receiving Omalizumab for Allergic Asthma in a Real-World Setting
  di: Braunstahl, Gert-Jan, et al.
  Pubblicazione: (2014)
• Reduction in oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma receiving omalizumab in a real-world setting
  di: Braunstahl, Gert-Jan, et al.
  Pubblicazione: (2013)
• Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting
  di: Braunstahl, Gert-Jan, et al.
  Pubblicazione: (2013)
• Efficacy of Allergen Immunotherapy for Allergic Asthma in Real World Practice
  di: Rhyou, Hyo-In, et al.
  Pubblicazione: (2019)
• Effectiveness of Omalizumab in Severe Allergic Asthma: A Retrospective UK Real-World Study
  di: Barnes, Neil, et al.
  Pubblicazione: (2013)